New Study Investigating if a Probiotic Supplement has the Potential to Help Manage Type II Diabetes

Share With Your Friends

Atlantia Launches New Study Investigating if a Probiotic Supplement has the Potential to Help Manage Type II Diabetes.

Diabetes mellitus and its comorbidities are currently a global public health crisis, with approximately 30 million people diagnosed with diabetes. Although diabetes is a multifactorial disease, it is widely believed that the increase in diabetes worldwide may be linked to the adoption of the Western diet. Recently, research has shown that the use of the Western diet has an impact on the gut microbiome, altering both the composition and activities of that microbiome – The microbiome refers to the bacteria, viruses, fungi, phage, and other microorganisms that reside in your intestine.

There is increasing evidence that the gut microbiome offers an opportunity for the development of novel ways to help manage a variety of diseases by modifying its composition. Bacterial strains in the gut microbiome ferment fibres in the colon to produce what are known as Short Chain Fatty Acids (SCFAS). These SCFAs bind with hormones, which are known to play a key role in the development and progression of diabetes.

The present study with Atlantia will investigate the use of a probiotic on the gut microbiome and its potential beneficial effects in the management of Type II Diabetes. In addition to its influence on diabetes, boosting the quantity of SCFAs may have a secondary benefit by protecting the gut barrier, preventing undesirable bacteria from entering the bloodstream.

A device known as a Continuous Glucose Monitor (CGM) will be used to measure the potential effect of the probiotic on glucose levels over the course of the study. The CGM is a small, button-sized device with a microneedle, which is placed on the upper arm. Once inserted, it continuously monitors glucose levels and the readings obtained are transferred to a remote device or smartphone for analysis.

Atlantia are seeking people with a diagnosis of Type II Diabetes, treated with Exercise and Diet alone or, in combination with Metformin. Successful applicants of the study will take the probiotic supplement twice daily, over a 12-week period. As with all studies run by Atlantia, all participants are offered a free health check at each visit which includes a full blood test, blood pressure and BMI check. Each participant will receive €575 upon completion of the study.

If you would like to take part in the study with Atlantia or if you are unsure that you qualify for the study based on the criteria above and would like to discuss it in more detail with one of their team you can call on 021-4307442 or contact their Recruitment team directly on 087-2254257.PRESS ON IMAGE TO CONTACT US.

If you are interested in getting involved in food research with Atlantia but do not meet the criteria for this study, there are a number of studies that are ongoing and still open for participation. All current and upcoming studies can be viewed on their website, at

Share With Your Friends